Amato, M.P., Bartolozzi, M.L., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., Siracusa, G.,
Sorbi, S., Federico, A.,De Stefano, N., 2004. Neocortical volume decrease in relapsingremitting
MS patients with mild cognitive impairment. Neurology 63, 89–93.
Anderson, V.M., 2006. Magnetic resonance imaging measures of brain atrophy in
multiple sclerosis. J. Magn. Reson. Imaging 23, 605–618.
Ashburner, J., Friston, K.J., 2000. Voxel-based morphometry—the methods. NeuroImage
11, 805–821.
Audoin, B., Davies, G.R., Finisku, L., Chard, D.T., Thompson, A.J., Miller, D.H., 2006.
Localization of grey matter atrophy in early RRMS. J. Neurol. 253, 1495–1501.
Borgwardt, S.J., McGuire, P.K., Aston, J., Berger, G., Dazzan, P., Gschwandtner, U., Pfluger,
M., D'Souza, M., Radue, E.W., Riecher-Rossler, A., 2007a. Structural brain
abnormalities in individuals with an at-risk mental state who later develop
psychosis. Br. J. Psychiatry Suppl. 51, s69–s75.
Borgwardt, S.J., Riecher-Rossler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M.,
Gschwandtner, U., Haller, S., Pfluger, M., Rechsteiner, E., D'Souza, M., Stieglitz, R.-D.,
Radu, E.-W., McGuire, P.K., 2007b. Regional gray matter volume abnormalities in
the at risk mental state. Biol. Psychiatry 61, 1148–1156.
Borgwardt, S.J., McGuire, P., Fusar-Poli, P., Radue, E.W., Riecher-Rossler, A., 2008a.
Anterior cingulate pathology in the prodromal stage of schizophrenia. NeuroImage
39, 553–554.
Borgwardt, S.J., McGuire, P., Aston, J., Gschwandtner, U., Pflueger, M., Stieglitz, R.D.,
Radue, E.W., Riecher-Rössler, A., 2008b. Reductions in frontal, temporal and parietal
volume associated with the onset of psychsis. Schizophrenia Research 106 (2–3),
20–26.
Brambati, S.M., Renda, N.C., Rankin, K.P., Rosen, H.J., Seeley,W.W., Ashburner, J.,Weiner,
M.W., Miller, B.L., Gorno-Tempini, M.L., 2007. A tensor based morphometry study of
longitudinal gray matter contraction in FTD. NeuroImage 35, 998–1003.
Ceccarelli, A., Rocca, M.A., Pagani, E., Colombo, B., Martinelli, V., Comi, G., Filippi, M.,
2008. A voxel-based morphometry study of grey matter loss in MS patients with
different clinical phenotypes. NeuroImage 42, 315–322.
Chard, D.T., Griffin, C.M., Parker, G.J.M., Kapoor, R., Thompson, A.J., Miller, D.H., 2002.
Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125,
327–337.
Chard, D.T., Griffin, C.M., Rashid, W., Davies, G.R., Altmann, D.R., Kapoor, R., Barker, G.J.,
Thompson, A.J., Miller, D.H., 2004. Progressive grey matter atrophy in clinically early
relapsing-remitting multiple sclerosis. Mult. Scler. 10, 387–391.
Charil, A., Dagher, A., Lerch, J.P., Zijdenbos, A.P., Worsley, K.J., Evans, A.C., 2007. Focal
cortical atrophy in multiple sclerosis: relation to lesion load and disability.
NeuroImage 34, 509–517.
Chen, J.T., Narayanan, S., Collins, D.L., Smith, S.M., Matthews, P.M., Arnold, D.L., 2004.
Relating neocortical pathology to disability progression in multiple sclerosis using
MRI. NeuroImage 23, 1168–1175.
Dalton, C.M., Chard, D.T., Davies, G.R., Miszkiel, K.A., Altmann, D.R., Fernando, K., Plant,
G.T., Thompson, A.J., Miller, D.H., 2004. Early development of multiple sclerosis is
associated with progressive grey matter atrophy in patients presenting with
clinically isolated syndromes. Brain 127, 1101–1107.
De Stefano, N., Matthews, P.M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M.L., Guidi,
L., Ghezzi, A., Montanari, E., Cifelli, A., Federico, A., Smith, S.M., 2003. Evidence of
early cortical atrophy in MS: relevance to white matter changes and disability.
Neurology 60, 1157–1162.
Evangelou, N., Konz, D., Esiri, M.M., Smith, S., Palace, J., Matthews, P.M., 2000. Regional
axonal loss in the corpus callosum correlates with cerebral white matter lesion
volume and distribution in multiple sclerosis. Brain 123, 1845–1849.
Fox, N.C., Jenkins, R., Leary, S.M., Stevenson, V.L., Losseff, N.A., Crum, W.R., Harvey, R.J.,
Rossor, M.N., Miller, D.H., Thompson, A.J., 2000. Progressive cerebral atrophy in MS:
a serial study using registered, volumetric MRI. Neurology 54, 807–812.
Fusar-Poli, P., Perez, J., Broome, M., Borgwardt, S., Placentino, A., Caverzasi, E., Cortesi,
M., Veggiotti, P., Politi, P., Barale, F., McGuire, P., 2007. Neurofunctional correlates of
vulnerability to psychosis: a systematic review and meta-analysis. Neurosci.
Biobehav. Rev. 31, 465–484.
Ge, Y., Grossman, R.I., Udupa, J.K., Wei, L., Mannon, L.J., Polansky, M., Kolson, D.L.,
2000. Brain atrophy in relapsing-remitting multiple sclerosis and secondary
progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214,
665–670.
Ge, Y., Grossman, R.I., Udupa, J.K., Babb, J.S., Nyul, L.G., Kolson, D.L., 2001. Brain atrophy
in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray
matter and white matter. Radiology 220, 606–610.
Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N.A., Friston, K.J., Frackowiak, R.S.J.,
2001. A voxel-based morphometric study of ageing in 465 normal adult human
brains. NeuroImage 14, 21–36.
Hardmeier, M., Wagenpfeil, S., Freitag, P., Fisher, E., Rudick, R.A., Kooijmans-
Coutinho, M., Clanet, M., Radue, E.W., Kappos, L., 2003. Atrophy is detectable
within a 3-month period in untreated patients with active relapsing remitting
multiple sclerosis. Arch. Neurol. 60, 1736–1739.
Hayasaka, S., Phan, K.L., Liberzon, I., Worsley, K.J., Nichols, T.E., 2004. Nonstationary
cluster-size inference with random field and permutation methods. NeuroImage
22, 676–687.
Kalkers, N.F., Ameziane, N., Bot, J.C.J., Minneboo, A., Polman, C.H., Barkhof, F., 2002.
Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy
is independent of the disease subtype. Arch. Neurol. 59, 1572–1576.
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C.H., Haas, T., Korn,
A.A., Karlsson, G., Radue, E.W., the, F.T.Y.D.S.G., 2006. Oral fingolimod (FTY720) for
relapsing multiple sclerosis. N. Engl. J. Med. 355, 1124–1140.
Kipps, C.M., Duggins, A.J., Mahant, N., Gomes, L., Ashburner, J., McCusker, E.A.,
2005. Progression of structural neuropathology in preclinical Huntington's
disease: a tensor based morphometry study. J. Neurol. Neurosurg. Psychiatry
76, 650–655.
Kutzelnigg, A., Lassmann, H., 2005. Cortical lesions and brain atrophy in MS. J. Neurol.
Sci. 233, 55–59.
Leow, A.D., Klunder, A.D., Jack Jr., C.R., Toga, A.W., Dale, A.M., Bernstein, M.A., Britson,
P.J., Gunter, J.L., Ward, C.P., Whitwell, J.L., Borowski, B.J., Fleisher, A.S., Fox, N.C.,
Harvey, D., Kornak, J., Schuff, N., Studholme, C., Alexander, G.E., Weiner, M.W.,
Thompson, P.M., 2006. Longitudinal stability of MRI for mapping brain change
using tensor-based morphometry. NeuroImage 31, 627–640.
Lin, X., Blumhardt, L.D., 2001. Inflammation and atrophy in multiple sclerosis: MRI
associations with disease course. J. Neurol. Sci. 189, 99–104.
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D.,
McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M.,
Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B.Y., Wolinsky, J.S.,
2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from
the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50,
121–127.
Miller, D.H., Barkhof, F., Frank, J.A., Parker, G.J.M., Thompson, A.J., 2002. Measurement of
atrophy in multiple sclerosis: pathological basis, methodological aspects and
clinical relevance. Brain 125, 1676–1695.
Molyneux, P.D., Kappos, L., Polman, C., Pozzilli, C., Barkhof, F., Filippi, M., Yousry, T.,
Hahn, D., Wagner, K., Ghazi, M., Beckmann, K., Dahlke, F., Losseff, N., Barker, G.J.,
Thompson, A.J., Miller, D.H., 2000. The effect of interferon beta-1b treatment on
MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. Brain
123, 2256–2263.
Moorhead, T.W.J., Job, D.E., Spencer, M.D., Whalley, H.C., Johnstone, E.C., Lawrie, S.M.,
2005. Empirical comparison of maximal voxel and non-isotropic adjusted cluster
extent results in a voxel-based morphometry study of comorbid learning disability
with schizophrenia. NeuroImage 28, 544–552.
Morgen, K., Sammer, G., Courtney, S.M., Wolters, T., Melchior, H., Blecker, C.R.,
Oschmann, P., Kaps, M., Vaitl, D., 2006. Evidence for a direct association between
cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage
30, 891–898.
Pagani, E., Rocca, M.A., Gallo, A., Rovaris, M., Martinelli, V., Comi, G., Filippi, M., 2005.
Regional brain atrophy evolves differently in patients with multiple sclerosis
according to clinical phenotype. AJNR Am. J. Neuroradiol. 26, 341–346.
Pirko, I., Lucchinetti, C.F., Sriram, S., Bakshi, R., 2007. Gray matter involvement in
multiple sclerosis. Neurology 68, 634–642.
Prinster, A., Quarantelli, M., Orefice, G., Lanzillo, R., Brunetti, A., Mollica, C., Salvatore, E.,
Morra, V.B., Coppola, G., Vacca, G., Alfano, B., Salvatore, M., 2006. Grey matter loss inrelapsing-remitting multiple sclerosis: a voxel-based morphometry study. Neuro-
Image 29, 859–867.
Quarantelli, M., Ciarmiello, A., Morra, V.B., Orefice, G., Larobina,M., Lanzillo, R., Schiavone,
V., Salvatore, E., Alfano, B., Brunetti, A., 2003. Brain tissue volume changes in relapsingremitting
multiple sclerosis: correlation with lesion load. NeuroImage 18, 360–366.
Rovaris, M., Comi, G., Rocca, M.A., Wolinsky, J.S., Filippi, M., 2001. Short-term brain
volume change in relapsing-remitting multiple sclerosis: effect of glatiramer
acetate and implications. Brain 124, 1803–1812.
Rudick, R.A., Fisher, E., Lee, J.C., Simon, J., Jacobs, L., 1999. Use of the brain parenchymal
fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 53,
1698–1704.
Sailer, M., Fischl, B., Salat, D., Tempelmann, C., Schonfeld, M.A., Busa, E., Bodammer, N.,
Heinze, H.-J., Dale, A., 2003. Focal thinning of the cerebral cortex in multiple
sclerosis. Brain 126, 1734–1744.
Sanfilipo, M.P., Benedict, R.H.B., Sharma, J.,Weinstock-Guttman, B., Bakshi, R., 2005. The
relationship between whole brain volume and disability in multiple sclerosis: a
comparison of normalized gray vs. white matter with misclassification correction.
NeuroImage 26, 1068–1077.
Sanfilipo, M.P., Benedict, R.H.B.,Weinstock-Guttman, B., Bakshi, R., 2006. Gray and white
matter brain atrophy and neuropsychological impairment in multiple sclerosis.
Neurology 66, 685–692.
Schmahmann, J.D., Doyon, J., McDonald, D., Holmes, C., Lavoie, K., Hurwitz, A.S., Kabani,
N., Toga, A., Evans, A., Petrides, M., 1999. Three-dimensional MRI atlas of the human
cerebellum in proportional stereotaxic space. NeuroImage 10, 233–260.
Sepulcre, J., Sastre-Garriga, J., Cercignani, M., Ingle, G.T., Miller, D.H., Thompson, A.J.,
2006. Regional gray matter atrophy in early primary progressive multiple sclerosis:
a voxel-based morphometry study. Arch. Neurol. 63, 1175–1180.
Talairach, J., Tournoux, P., 1998. Co-planar stereotaxic atlas of the human brain. Thieme
Medical Publishers, New York.
Tiberio, M., Chard, D.T., Altmann, D.R., Davies, G., Griffin, C.M., Rashid, W., Sastre-
Garriga, J., Thompson, A.J., Miller, D.H., 2005. Gray and white matter volume
changes in early RRMS: a 2-year longitudinal study. Neurology 64, 1001–1007.
Trapp, B.D., Nave, K.-A., 2008. Multiple sclerosis: an immune or neurodegenerative
disorder? Annu. Rev. Neurosci. 31, 247–269.
White, T., O'Leary, D., Magnotta, V., Arndt, S., Flaum, M., Andreasen, N.C., 2001. Anatomic
and functional variability: the effects of filter size in group fMRI data analysis.
NeuroImage 13, 577–588.
Zivadinov, R., Sepcic, J., Nasuelli, D., De Masi, R., Bragadin, L.M., Tommasi, M.A., Zambito-
Marsala, S., Moretti, R., Bratina, A., Ukmar, M., Pozzi-Mucelli, R.S., Grop, A., Cazzato,
G., Zorzon, M., 2001. A longitudinal study of brain atrophy and cognitive
disturbances in the early phase of relapsing-remitting multiple sclerosis. J. Neurol.
Neurosurg. Psychiatry 70, 773–780.